Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000897069-25-000668·Tracy Thomas Joseph
Schedule 13D ownership disclosure
TRANSCODE THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 89357L402
Event date: 2025-03-07
- Filing-level shares
- 35,000
- Percent of class
- 5%
- Thomas Joseph TracyReported CIK 0002062715
Shares: 35,000 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897069-25-000668
- Form type
- SCHEDULE 13D
- Filer
- Tracy Thomas Joseph
- CIK
- CIK 2062715
- Filed
- Mar 20, 2025
- Reporting period
- Mar 07, 2025
- Description
- Schedule 13D beneficial ownership